Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Potential Genomic Alterations Using Pan-Cancer Cell-Free DNA Next-Generation Sequencing in Patients With Gastric Cancer.

Annals of laboratory medicine - 1 Mar 2024

Kim Boyeon, Kim Yoonjung, Cho Jae Yong, Lee Kyung-A

Abstract excerpt

Background: Molecular cancer profiling may lead to appropriate trials for molecularly targeted therapies. Cell-free DNA (cfDNA) is a promising diagnostic and/or prognostic biomarker in gastric cancer (GC). We characterized somatic genomic alterations in cfDNA of patients with GC. Methods: Medical records and cfDNA data of 81 patients diagnosed as having GC were reviewed. Forty-nine and 32 patients were tested...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell-Free Nucleic Acids

Share to Genomics

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Stomach Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 37903652
DOI: 10.3343/alm.2023.0187
PMCID: PMC10628753

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Potential Genomic Alterations Using Pan-Cancer Cell-Free DNA Next-Generation Sequencing in Patients With Gastric Cancer.PMID 37903652Read ↗

Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencingSemantic proximity Read ↗

Multimodal analysis of cell-free DNA to improve early detection of gastric cancer.Semantic proximity Read ↗

Liquid Biopsy in Gastric Cancer: Analysis of Somatic Cancer Tissue Mutations in Plasma Cell-Free DNA for Predicting Disease State and Patient Survival.Semantic proximity Read ↗

Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.Semantic proximity Read ↗

Deep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine.Semantic proximity Read ↗

An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.Semantic proximity Read ↗

Validation of a targeted sequencing panel with automatic analysis system for clinical decision support in cancer therapySemantic proximity Read ↗

Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.Semantic proximity Read ↗

Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry: A Novel Path for Precision Oncology.Semantic proximity Read ↗

Genome-Scale Methylation Analysis of Circulating Cell-Free DNA in Gastric Cancer PatientsSemantic proximity Read ↗

Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients.Semantic proximity Read ↗

Cell‑free DNA as a liquid biopsy for early detection of gastric cancer (Review)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.